These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9532017)

  • 21. The potential impact of the reperfusion injury on acute and chronic rejection events following organ transplantation.
    Land W
    Transplant Proc; 1994 Dec; 26(6):3169-71. PubMed ID: 7998106
    [No Abstract]   [Full Text] [Related]  

  • 22. [TAC/MMF/Pred/single shot ATG versus CsA/MMF/Pred single shot ATG after pancreas-/kidney transplantation (PNTX)--initial results of a prospective randomized study].
    Schulz T; Heimes M; Schindler A; Büsing M
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):141-5. PubMed ID: 14518229
    [No Abstract]   [Full Text] [Related]  

  • 23. Changes of antigenicity and loss of immunogenicity in long-standing class I MHC disparate pancreas allografts.
    Klempnauer J; Jörns A; Frericks BB; Bektas H
    Transplant Proc; 1997; 29(1-2):1151. PubMed ID: 9123244
    [No Abstract]   [Full Text] [Related]  

  • 24. Patterns of rejection after combined pancreas-kidney transplantation.
    Stratta RJ; Taylor RJ; Bynon JS; Lowell JA; Frisbie K; Brennan DC; Radio SJ; Cattral MS
    Transplant Proc; 1994 Apr; 26(2):524-5. PubMed ID: 8171536
    [No Abstract]   [Full Text] [Related]  

  • 25. Tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation.
    Peddi VR; Demmy AM; Munda R; Alexander JW; First MR
    Transplant Proc; 1998 Mar; 30(2):509-11. PubMed ID: 9532151
    [No Abstract]   [Full Text] [Related]  

  • 26. First results with a quadruple therapy regimen including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation.
    Kahl A; Bechstein WO; Platz K; Müller A; Berweck S; Venz S; Neuhaus P; Frei U
    Transplant Proc; 1998 Mar; 30(2):505-6. PubMed ID: 9532149
    [No Abstract]   [Full Text] [Related]  

  • 27. Neonatal tolerance induction in diabetes-prone BB rats as a model for donor-specific pancreas transplantation during adulthood.
    Nakai I; Oka T; Field JM; Najarian JS; Sutherland DE; Brayman KL
    Transplant Proc; 1992 Dec; 24(6):2902. PubMed ID: 1465991
    [No Abstract]   [Full Text] [Related]  

  • 28. Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes.
    Cooper JE; Gralla J; Cagle L; Goldberg R; Chan L; Wiseman AC
    Transplantation; 2011 May; 91(10):1103-9. PubMed ID: 21403588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunologic mechanisms inducing tolerance to allografts].
    Martorell J
    Nefrologia; 2004; 24 Suppl 4():67-71. PubMed ID: 15279390
    [No Abstract]   [Full Text] [Related]  

  • 30. Simultaneous pancreas/kidney transplantation: comparison of mycophenolate mofetil versus azathioprine.
    Elkhammas EA; Yilmaz S; Henry ML; Yenchar J; Bumgardner GL; Pelletier RP; Ferguson RM
    Transplant Proc; 1998 Mar; 30(2):512. PubMed ID: 9532152
    [No Abstract]   [Full Text] [Related]  

  • 31. Are kidney and pancreas rejection simultaneous events in combined transplants in dogs?
    Wilson TG; Hawthorne WJ; Greenberg ML; Earl MJ; Grierson JM; O'Neill P; Yung T; Chapman JR; Little JM; Allen RD
    Transplant Proc; 1990 Oct; 22(5):2159-60. PubMed ID: 2219328
    [No Abstract]   [Full Text] [Related]  

  • 32. Transplantation of insulin-secreting tissues.
    Karl RC; Scharp DW; Ballinger WF; Lacy PE
    Gut; 1977 Dec; 18(12):1062-72. PubMed ID: 414967
    [No Abstract]   [Full Text] [Related]  

  • 33. Transplantation of the pancreas, 1978.
    Jonasson O
    Transplant Proc; 1979 Mar; 11(1):325-30. PubMed ID: 109962
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation.
    Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Pellar S; Josephson MA; Thistlethwaite JR
    Transplant Proc; 1998 Mar; 30(2):507-8. PubMed ID: 9532150
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation.
    Lehrich RW; Rocha PN; Reinsmoen N; Greenberg A; Butterly DW; Howell DN; Smith SR
    Hum Immunol; 2005 Apr; 66(4):350-8. PubMed ID: 15866697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release of interleukins during tolerance and rejection of human renal allografts.
    Charpentier B; Lantz O; Lang P; Martin B; Fries D
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1572-3. PubMed ID: 3274385
    [No Abstract]   [Full Text] [Related]  

  • 37. Differential immunosuppressive strategies after combined pancreaticoduodenal and isolated kidney transplantation.
    Mellert J; Hopt UT; Büsing M; Hölzer H
    Transplant Proc; 1990 Aug; 22(4):1584-5. PubMed ID: 2389412
    [No Abstract]   [Full Text] [Related]  

  • 38. Isolated pancreas rejection in combined kidney-pancreas transplantation: results of percutaneous pancreas biopsy.
    Klassen DK; Weir MR; Schweitzer EJ; Bartlett ST
    Transplant Proc; 1995 Feb; 27(1):1333-4. PubMed ID: 7533380
    [No Abstract]   [Full Text] [Related]  

  • 39. Pancreas transplantation for treatment of diabetes mellitus.
    Sutherland DE; Gruessner RW; Gruessner AC
    World J Surg; 2001 Apr; 25(4):487-96. PubMed ID: 11344403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Perspective of simultaneous pancreas-kidney transplantation].
    Schenker P; Viebahn R
    Dtsch Med Wochenschr; 2013 May; 138(18):958-63. PubMed ID: 23613377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.